Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Donor heart selection: Wythenshawe experience.

N Khasati1, J Barnard, M N Bittar

  • 1From the Transplant Centre, South Manchester University Hospitals NHS Trust, Manchester, England.

Transplantation Proceedings
|April 26, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapy-related myelodysplastic syndromes-specific risk stratification: are we putting the cart before the horse?

Leukemia·2017
Same author

Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on behalf of the MDS Clinical Research Consortium.

Leukemia·2017
Same author

Longitudinal analysis of reporting and quality of systematic reviews in high-impact surgical journals.

The British journal of surgery·2016
Same author

Maritime in transit care.

Journal of the Royal Naval Medical Service·2016
Same author

Comparison of risk stratification tools in predicting outcomes of patients with higher-risk myelodysplastic syndromes treated with azanucleosides.

Leukemia·2015
Same author

Altered Immunogenicity of Donor Lungs via Removal of Passenger Leukocytes Using Ex Vivo Lung Perfusion.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015

Donor hearts medically unsuitable for transplantation at one center showed significantly higher recipient mortality. Caution is advised when using these grafts, especially with multiple adverse factors, to improve heart transplant outcomes.

Area of Science:

  • Cardiovascular Surgery
  • Transplantation Medicine
  • Organ Donation

Background:

  • Declining availability of suitable donor hearts necessitates exploring utilization of previously unacceptable donors.
  • Investigating outcomes of donor hearts deemed medically unsuitable by one center but transplanted elsewhere.

Purpose of the Study:

  • To evaluate the clinical outcomes of heart transplant recipients receiving grafts from donors initially declined for medical reasons.

Main Methods:

  • Retrospective analysis of 40 medically unsuitable donor hearts (Group 1) versus 104 suitable donor hearts (Group 2) transplanted between April 1998 and March 2003.
  • Data sourced from the United Kingdom Cardiothoracic Transplant Audit database.
  • Mortality analysis performed using SPSS software.

Related Experiment Videos

Main Results:

  • Significantly higher mortality observed in recipients of Group 1 donor hearts compared to Group 2 (P < .0009).
  • Graft failure accounted for 50% of early deaths in the medically unsuitable donor group.
  • High-dose inotrope use, prolonged ischemic time (>3.5 hours), and high-risk recipients were associated with poor outcomes in Group 1.

Conclusions:

  • Donor hearts declined on medical grounds require careful evaluation before transplantation.
  • The presence of multiple adverse factors in a donor heart significantly increases transplant risk.